Skip to main content
. 2021 Feb 1;13(2):194. doi: 10.3390/pharmaceutics13020194

Table 1.

Baseline characteristics of patients and study eyes. (BCVA = best-corrected visual acuity; CSMT = central subfield macular thickness; HIP = high intraocular pressure).

Characteristics
Mean Age, Years (Range) 65.8 Years (34.9–86.1)
Mean follow-up, months (±SD) 16.5 (±11.4)
Mean BCVA, ETDRS letters (±SD) 54.0 (±18.1)
Mean subfield central macular thickness (CSMT), μm (±SD) 476.4 (±142.6)
Mean IOP, mmHg (±SD) 14.5 (±3.0)
Eye Right Left
54 (42%) 75 (58%)
Sex F M
67 (52%) 62 (48%)
Lens status Phakic Pseudophakic
60 (46%) 69 (54%)
Diabetes Type 1 Type 2
13 (10%) 116 (90%)
Number of Patients with (%)
High blood pressure 94 (73%)
Glaucoma/HIP 6 (4.5%)
Vitrectomy 5 (4%)
Panretinal photocoagulation (PRP) 73 (56%)
Focal laser 26 (21%)
Subretinal Fluid (SRF) 15 (12%)
Central Exudates 14 (11%)
Hyperreflective foci 44 (34%)
Ellipsoid Zone Alterations (EZA) 40 (31%)
Disorganization of Retinal Inner Layers (DRIL) 41 (32%)
DRIL or EZA 58 (45%)